Trials / Terminated
TerminatedNCT03050372
Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep
Double-Blind, Sham-Controlled Crossover Pilot Study of Low Field Magnetic Stimulation (LFMS) on Subjective and Objective Measures of Sleep
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Participants will be recruited and screened through ongoing studies in the sleep and anxiety disorders clinic. Participants with insomnia will be consented to complete several questionnaires, undergo a brief physical exam, provide a urinalysis, and undergo 5 nights of active or sham Low Field Magnetic Stimulation (LFMS) followed by an overnight sleep study. Each of the two treatment conditions (active versus sham) will be conducted on two consecutive nights. There will be no more than 7 days between the adaptation night and the first treatment condition and no more than 7 nights between each of the two-night treatment conditions . Thus, each participant who completes the full study will spend a total of 5 nights in the sleep laboratory and the time interval from the first adaptation night to completion of the study may range from 5-19 days for any particular individual.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LFMS - Active | A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes) |
| DEVICE | LFMS - Sham | A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes) |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-02-10
- Last updated
- 2020-02-13
- Results posted
- 2020-02-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03050372. Inclusion in this directory is not an endorsement.